Search

Your search keyword '"γ-cyclodextrin"' showing total 459 results

Search Constraints

Start Over You searched for: Descriptor "γ-cyclodextrin" Remove constraint Descriptor: "γ-cyclodextrin"
459 results on '"γ-cyclodextrin"'

Search Results

1. 2‐Hydroxybenzaldehyde Azine and γ‐Cyclodextrin Based Colorimetric/Fluorescent Probe for Highly Sensitive and Selective Detection of Cu2+.

2. Effect of cinnamon essential oil/γ‐cyclodextrin inclusion complex on papaya quality and shelf‐life.

3. γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application

4. Beneficial Effects of Resveratrol and γ-Cyclodextrin on the Hematological and Biochemical Parameters of Healthy Wistar Rats Treated with Cisplatin: A PCA Approach.

5. Influence of Complexation with β- and γ-Cyclodextrin on Bioactivity of Whey and Colostrum Peptides.

6. Aqueous-phase room-temperature afterglow crystalline micro/nanostructures via supramolecular inclusion complexation of γ-cyclodextrin with difluoroboron β-diketonate luminescence compounds

7. Preparation of C-Terminal Epitope Imprinted Particles for Recognition of Cytochrome c Assisted with γ-Cyclodextrin by Host-Guest Interaction.

9. Enantioselective Labeling of Zebrafish for D-Phenylalanine Based on Graphene-Based Nanoplatform.

10. Encapsulation of vortioxetine with cyclodextrins via host–guest inclusion complex: Synthesis, characterization, solubility, and in vitro dissolution studies.

11. Nanoprecipitates of γ‐cyclodextrin/epigallocatechin‐3‐gallate inclusion complexes as efficient antioxidants for preservation of shrimp surimi products: synthesis, performance and mechanism.

12. Preparation and Spectroscopic Characterization of Ternary Inclusion Complexes of Ascorbyl Palmitate and Urea with γ-Cyclodextrin.

13. Direct chiral separation of abscisic acid by high‐performance liquid chromatography with a phenyl column and a mobile phase containing γ‐cyclodextrin.

14. Supramolecular Host–Guest Assemblies of [M 6 Cl 14 ] 2– , M = Mo, W, Clusters with γ-Cyclodextrin for the Development of CLUSPOMs.

15. Carboxymethyl cellulose-based injectable hydrogel loaded with a composite of melatonin and γ-cyclodextrin with antioxidant property for diabetic wound repair.

16. Development and Characterization of Pharmaceutical Systems Containing Rifampicin.

17. Regularities of Encapsulation of Tolfenamic Acid and Some Other Non-Steroidal Anti-Inflammatory Drugs in Metal-Organic Framework Based on γ-Cyclodextrin.

18. Tilmicosin/γ-Cyclodextrin complexation through supercritical carbon dioxide assistance and its pharmacokinetic and antibacterial study.

19. 植物精油与环糊精包合物的制备及对柑橘绿霉病的抑制作用.

20. Targeted quercetin delivery nanoplatform via folic acid-functionalized metal-organic framework for alleviating ethanol-induced gastric ulcer.

21. Beneficial Effects of Resveratrol and γ-Cyclodextrin on the Hematological and Biochemical Parameters of Healthy Wistar Rats Treated with Cisplatin: A PCA Approach

22. Influence of Complexation with β- and γ-Cyclodextrin on Bioactivity of Whey and Colostrum Peptides

23. Comparison of thermo-rheological, microstructural and antimicrobial properties of β- and γ-cyclodextrin inclusion complexes of cinnamon essential oil.

24. Preparation of γ-Cyclodextrin Inclusion Compounds Using Solid-Phase Guest Exchange Method.

25. Encapsulating quercetin in cyclodextrin metal–organic frameworks improved its solubility and bioavailability.

26. Lanthanide (Eu 3+ /Tb 3+)-Loaded γ-Cyclodextrin Nano-Aggregates for Smart Sensing of the Anticancer Drug Irinotecan.

27. Thermal, structural, antimicrobial, and physicochemical characterisation of thyme essential oil encapsulated in β- and γ-cyclodextrin.

28. One-pot synthesis of γ-cyclodextrin of high purity from non-food cellulose via an in vitro ATP-free synthetic enzymatic biosystem.

29. Adsorption Dynamics of Uremic Toxins to Cyclodextrin-Coated Magnetic Nano-Adsorbents.

30. Tetraphenylborate enhanced enzymatic production of γ-cyclodextrin: System construction and its mechanism.

31. Biocompatible hydrophobic cross-linked cyclodextrin-based metal-organic framework as quercetin nanocarrier for enhancing stability and controlled release.

32. Effect of pH on Ellagic acid and its complexation with gamma-cyclodextrins.

33. Enantioselective Labeling of Zebrafish for D-Phenylalanine Based on Graphene-Based Nanoplatform

34. Preparation and Spectroscopic Characterization of Ternary Inclusion Complexes of Ascorbyl Palmitate and Urea with γ-Cyclodextrin

35. Simultaneous spectrofluorometric analysis of caffeic and ellagic acids through inclusion complex formation with γ-cyclodextrin.

36. Enrofloxacin/florfenicol loaded cyclodextrin metal-organic-framework for drug delivery and controlled release

37. γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application.

38. The Emerging Role of Cyclodextrin Metal–Organic Frameworks in Ostheotherapeutics.

39. Gamma cyclodextrin glycosyltransferase from evansella caseinilytica: production, characterization and product specificity.

40. Gamma cyclodextrin glycosyltransferase from evansella caseinilytica: production, characterization and product specificity.

41. Crystal structure of a two-dimensional metal–organic framework assembled from lithium(I) and γ-cyclodextrin

42. Supramolecular Host–Guest Assemblies of [M6Cl14]2–, M = Mo, W, Clusters with γ-Cyclodextrin for the Development of CLUSPOMs

43. Development and Characterization of Pharmaceutical Systems Containing Rifampicin

44. Regularities of Encapsulation of Tolfenamic Acid and Some Other Non-Steroidal Anti-Inflammatory Drugs in Metal-Organic Framework Based on γ-Cyclodextrin

45. Hydrophobic ion pairing with cationic derivatives of α-, ß-, and γ-cyclodextrin as a novel approach for development of a self-nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin.

46. Encapsulation of hexanal in bio-based cyclodextrin metal organic framework for extended release.

47. Covalent modification of γ-cyclodextrin with geraniol: An antibacterial agent with good thermal stability, solubility and biocompatibility.

48. Exploring oral drug delivery: In vitro release and mathematical modeling of hydrophobic drug (Na-L-thyroxine) and its cyclodextrin inclusion complex in chitosan microparticles.

49. Encapsulation of (-)-epigallocatechin gallate (EGCG) within phospholipid-based nanovesicles using W/O emulsion-transfer methods: Masking bitterness and delaying release of EGCG.

50. Carboxymethyl potato starch hydrogels encapsulated cyclodextrin metal-organic frameworks for enantioselective loading of S-naproxen and its programmed release.

Catalog

Books, media, physical & digital resources